CDC and FDA Declares Joint Statement in Johnson & Johnson COVID vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are giving a second thought and declaring a pause on the Johnson & Johnson COVID vaccine this April 2021 for the safety of the people.

COVID19 vaccine is given top priority these days. People worldwide are trying all kinds of immune boosters to help them stay away from viruses. Pharma companies are giving in their best to come out with efficient vaccines and medicines that can help the general public. The governments of all countries worldwide are executing various plans that can help stop the spread of coronavirus.  Right from imposing restrictions to lockdown, the government has put in a lot of effort to curb coronavirus spread.

The authorization of the COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have gone ahead and given the green flag to COVID  vaccines for use by the general public worldwide. They have approved COVID vaccines under the Emergency Authorization Use for the betterment of the people. The  Food and Drug Administration (FDA) is working to address the concerns about vaccines among people, to protect and promote the health of the entire population. They are focussing on the strategies that address health disparity.

Side effects of the COVID vaccine are a major concern 

The use of the coronavirus vaccine has brought about a major concern of side effects in immunized people. The major fear of blood clots has been rising among the people about the coronavirus vaccine. This has been noticed in people receiving the Johnson & Johnson (J&J) vaccine which has been administered. The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are reviewing data of the six cases reported by the USA  where cases of rare and severe blood clots in the individual have been seen after receiving the  Johnson & Johnson (J&J) vaccine. A type of blood clot called Cerebral Venous Sinus Thrombosis(CVST) was seen in a combination of low platelet count, Thrombocytopenia. 

Details of the six cases detected an under review by The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)

All six cases which are under review were seen in the age group between 18 - 48. The symptoms of the blood clot called Cerebral Venous Sinus Thrombosis(CVST) and Thrombocytopenia occurred between 6 - 13 days after vaccination. Administering the COVID vaccine is led to this side effect of blood clots which needs immediate medical attention by The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The general conventional treatment of administering the anticoagulant called heparin is used to treat blood clots may be dangerous. We need to make sure that the vaccine has no interactions with the conventional treatment that is used by the patients. 

FDA ensures efficacy and safety of COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)  will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) to further review these six cases of blood clot side effects with COVID vaccine that has come into light this April 2021. FDA will review the analysis and also instigate the cases. Until the process is complete and under review, The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are recommending a pause to the use of the vaccine which is the need of the hour. This is a very important announcement by the FDA to ensure that healthcare professionals are aware of the side effects of this vaccine.

Tags : #medicircle #myhealth #FDA #CDC #COVIDvaccine #COVIDvaccinesideeffects

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026
A Practical Guide to Fibre: How Indian Adults Can Add More Without Digestive DiscomfortSeptember 12, 2026
Understanding Heart Palpitations: Common Triggers, Helpful Records, and Warning SignsSeptember 12, 2026
The Fourth Trimester: Why Healthcare Often Stops Too Early After DeliverySeptember 12, 2026
Postpartum Mental Health: The Healthcare Gap Nobody Talks About EnoughSeptember 12, 2026
Fortis Escorts Faridabad Launches Region’s First Dedicated ‘Fever Clinic’ for Early Diagnosis and Timely TreatmentSeptember 11, 2026
Aksigen IVF Expands Science-led Fertility Care with New Integrated Centre in PanvelSeptember 11, 2026
MGM Cancer Institute Marks World Rose Day with Milestone of 100 Bone Marrow Transplants and Launch of SwasthiSeptember 11, 2026